Although this is hardly the good news everyone was hoping for it is still better than where we were last month. Actually we were already on track to increase share count to 500 million and the leak out agreements were about to expire. We were at 2.6 cents 3 weeks ago. We were definitely on track to go sub-penny. The new leak out agreements appear to be pretty favorable. The A/S count is not what is most important, it's how many shares they can sell that is most important since that is what causes the price to tank and the share count to increase exponentially. . If the stock price stays up, it will significantly limit the amount of dilution. If there is any good news and the price pops, then that would help even more.
Maybe someone here can explain something for me: After the R/S, we were at about 7 million shares, today maybe 40- 50 million. So say the lenders converted 35 million shares since the reverse split. At say an average price of 15 cents (they have been diluting and selling since last Fall- many shares were no doubt converted above 20 cents) that would be about $6- 7 million of the balance owed could already be repaid- correct?
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links